Island Pharmaceuticals Ltd (ILA) — Financial Flexibility Index
Island Pharmaceuticals Ltd (ILA) has a Financial Flexibility Index of -5.03x as of June 2025. Free cash flow of AU$-1.69 Million (operating CF AU$-1.69 Million minus capex AU$5.00) represents -5% of total liabilities (AU$336.43K). Check Island Pharmaceuticals Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Island Pharmaceuticals Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Island Pharmaceuticals Ltd across 6 annual periods. For the full cash flow conversion analysis, see ILA cash flow conversion.
Annual Financial Flexibility Index for Island Pharmaceuticals Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Island Pharmaceuticals Ltd. Explore Island Pharmaceuticals Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.23x | AU$-2.77 Million | AU$-2.77 Million | AU$336.43K | ▼ -171.9% |
| 2023 | -3.03x | AU$-3.16 Million | AU$-3.16 Million | AU$1.05 Million | ▲ +70.5% |
| 2022 | -10.27x | AU$-2.71 Million | AU$-2.71 Million | AU$263.85K | ▼ -217.5% |
| 2021 | -3.23x | AU$-1.88 Million | AU$-1.88 Million | AU$580.73K | ▲ +18.4% |
| 2020 | -3.96x | AU$-938.23K | AU$-938.24K | AU$236.83K | ▼ -16588.4% |
| 2019 | -0.02x | AU$-16.00 | AU$-16.00 | AU$674.00 | — |